TIDMAMS

RNS Number : 9014V

Advanced Medical Solutions Grp PLC

27 July 2018

 
   27 July 2018

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Notice of Interim Results

Winsford, UK, 27 July 2018: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, will announce its interim results for the six months ended 30 June 2018 on Wednesday 12 September 2018.

A briefing for analysts will be held at 10.30am BST on the day of results in The Dome Room at 1 Cornhill, London EC3V 3ND. Please contact Consilium Strategic Communications for further details.

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group plc                    Tel: +44 (0) 1606 
                                                                    545508 
 Chris Meredith, Chief Executive Officer 
  Mary Tavener, Chief Financial Officer 
 
 Consilium Strategic Communications                   Tel: +44 (0) 20 3709 
                                                                      5700 
 Mary-Jane Elliott / Matthew Neal / Nicholas       AMS@consilium-comms.com 
  Brown / Olivia Manser 
 
 Investec Bank PLC (NOMAD & Broker)                   Tel: +44 (0) 20 7597 
                                                                      5970 
 Daniel Adams / Gary Clarence / Patrick 
  Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORFQLFLVDFFBBV

(END) Dow Jones Newswires

July 27, 2018 02:01 ET (06:01 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Advanced Medical Solutions Charts.